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Background
Currently, the titers of biopharmaceutical production
from Chinese hamster ovary (CHO) cells have achieved
gram per liter range and this can be attributed to
advances in bioprocess development, media develop-
ment and cell line development. To obtain high produ-
cing cell lines, extensive screening of producer clones
during cell line development is often necessary. To
improve the efficiency and efficacy of generating and
isolating high producing clones, various expression vec-
tor engineering technologies can be applied, for example
ubiquitous chromatin opening element (UCOE) [1],
matrix attachment regions (MARs) [2](Mirkovitch et al.
1984), site specific recombination [3-9], to improve
selection stringency [10-13], and to co-localize the GOI
with the selection marker [14-16].
In our previous studies, we have similarly shown that
specific productivities can be improved when we
increased selection stringency by destabilizing the selec-
tion marker through the addition of AU-rich elements
(ARE) to promote mRNA degradation and murine
ornithine decarboxylase (MODC) PEST region to
enhance protein degradation [17]. While coexpression of
GOI and selection marker using multiple promoters on
the same vector may help in the co-localization, we have
previously demonstrated that gene fragmentation can
occurs at a high level of 14% during stable transfection of
dual promoter dicistronic vector in CHO-DG44 cells
[18]. Subsequently, an attenuated IRES element was used
together with the PEST region to allow for high recombi-
nant protein titer using stably amplified cell pools [19].
In this study, we evaluated the use of tandem PEST
sequence, further attenuation of the IRES element, and
codon-deoptimization of the dhfr selection marker, to
further optimizing the strength of selection marker
expression in CHO cells for the production of recombi-
nant human Alpha1-antitrypsin (rhA1AT), a serum pro-
tease inhibitor currently purified from human blood
plasma as replacement therapy for patients who devel-
oped chronic obstructive pulmonary disease due to defi-
ciency in the protein. Such vector combinations to
attenuate translation initiation, protein elongation and
protein stability for optimizing selection stringency have
not been previously investigated. To our knowledge,
there is also no report on high-titer production of
rhA1AT in CHO cells, which is necessary for its manu-
facturability due to its high dosage requirement.
Experimental approach
7 expression vectors expressing rhA1AT that can be clas-
sified into 3 sets (Figure 1) were designed. Using rhA1AT
as the gene of interest, the first vector set consists of
pAID, pAIDp and pAIDpp. Comparing data from the use
of pAIDp against pAID will allow us to validate the use
of PEST element in improving stable recombinant gene
expression, as observed in our previous studies [17,19].
The application of 2 tandem PEST elements in pAIDpp
then allowed us to determine whether an additional
PEST can further improve stable recombinant gene
expression, as this has not been demonstrated in litera-
ture to our knowledge. The second vector set consists of
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pAI709Dp and pAI772Dp. These 2 vectors incorporated
mutations described by Hoffman MA and Palmenberg
AC [20] into the attenuated IRES [21,22]. This is to eval-
uate whether the further attenuation of selection marker
expression with these additional impediment in transla-
tion initiation can improve stable recombinant gene
expression. The third vector set comprised of pAID* and
pAID*p. These 2 vectors incorporated a codon de-opti-
mized dhfr selection marker to evaluate the use of codon
deoptimization as a strategy to further reduce selection
marker expression levels, since it will theoretically reduce
translation efficiency, a different aspect of gene expres-
sion that is not affected by the attenuated IRES and
PEST. The selection and amplification efficiency, recom-
binant protein productivity, relative transcript copy num-
bers and dhfr expression levels were then analyzed.
Results and discussion
pAIDpp and pAI772Dp vectors gave further improve-
ments in rhA1AT production when compared to pAID
and pAIDp vectors, indicating that further selection
marker attenuation can improve recombinant protein
production. Using the pAI772Dp vector, we generated a
cell pool that gave a maximum titer of 1.05 g/l of
rhA1AT in an un-optimized shake flask batch culture
using a 2-step amplification till 50 nM MTX that took
less than 3 months (Table 1). Using the pAI772Dp and
pAIDpp vectors, we generated cell pools that gave a
maximum titer of 1.11 and 1.15 g/l respectively in un-
optimized shake flask batch cultures at 300 nM MTX
(Table 1). To our knowledge, this is the highest reported
recombinant protein titer from shake flask cultures of
stable mammalian cell pools.
Relative transcript copy numbers demonstrated that
the transcription of rhA1AT and dhfr genes were corre-
lated due to the IRES linkage, although the results also
suggested that the protein expression were not solely
dependent on transcript levels. Protein level analysis of
dhfr validated that the cell pools were indeed expressing
the modified dhfr of the correct molecular weight. In
addition, it showed that the strategies of further attenu-
ating dhfr protein expression with the use of a mutated
IRES and tandem PEST, but not codon deoptimization,
were effective in reducing dhfr protein levels in these
MTX amplified cell pools in suspension serum free cul-
ture. Our data suggests the codon usage of surviving
Figure 1 Strategies for selection marker attenuation.
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cells with codon deoptimized selection marker may be
changed in our culture conditions to enable better cell
survivability. Hence, this result suggest that codon usage
of the selection marker should be considered for appli-
cations that involve gene amplification and serum free
suspension culture, since the general expression and
regulation of host cell proteins may be affected due to a
change in codon usage in the surviving cells.
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Table 1 Growth and productivity of top cell pools.
MTX
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50 nM pAID 256 17.6 46 5.6 256 17.6 46
pAIDp 492 25.7 36 4.2 244 10.9 36 3.1 368 18.3 36
pAIDpp 647 29.0 33 4.4 539 25.9 44 5.4 593 27.5 39
pAI772Dp 1054 41.3 28 8.5 937 33.8 26 8.2 996 37.6 27
pAID* 275 14.4 41 3.1 170 7.8 40 2.2 222 11.1 40
pAID*p 277 8.4 33 2.0 277 8.4 33
300 nM pAID 560 32.5 34 2.2 560 32.5 34
pAIDp 514 25.8 33 1.0 240 13.1 37 1.0 377 19.5 35
pAIDpp 1146 88.2 45 1.8 846 41.9 41 1.6 996 65.0 43
pAI772Dp 1111 48.6 42 1.1 863 35.4 27 0.9 987 42.0 34
pAID* 721 34.3 43 2.6 398 22.1 33 2.3 559 28.2 38
pAID*p 412 17.7 29 1.5 412 17.7 29
1 Maximum titer was taken as the highest rhA1AT titer assayed from the first 11 days of the batch culture.
2 Fold titer increase for cell pools in 50 nM MTX suspension culture was compared against the titers of the same cell pools in adherent 96 well plate cultures,
whereas that for cell pools in 300 nM MTX suspension culture was compared against the titers of the same cell pools in 50 nM MTX suspension culture.
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